U.S. stocks pushed higher on Wednesday, extending a powerful rally that has already driven major…
Read More »
Big Tech’s latest earnings cycle confirmed one thing clearly: the AI boom is real, accelerating, and already reshaping the revenue…
Read More »
Intel’s (INTC) comeback has quickly turned into one of the most dramatic stories in the market this year. S
Read More »
Software stocks had one of their strongest weekly rallies in decades, helping flip a previously lagging segment of the market…
Read More »
Zymeworks soared 34% after its partnered drug Ziihera posted strong Phase 3 data, with Jazz Pharmaceuticals showing it improved outcomes…
Read More »
Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist…
Read More »
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast…
Read More »
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster…
Read More »
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after…
Read More »
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by…
Read More »
Cannabis stocks rallied this Friday after reports that the Trump administration is considering easing federal…
Read More »
